MCL coexpression mm9:780: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:52, 17 September 2013
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr11:20731012..20731056,- | p1@1110067D22Rik |
Mm9::chr11:20731063..20731077,- | p5@1110067D22Rik |
Mm9::chr11:79153084..79153137,+ | p2@Nf1 |
Mm9::chr11:86570985..86571074,- | p1@Cltc |
Mm9::chr15:81641878..81641921,+ | p1@Tef |
Mm9::chr18:36440723..36440805,+ | p1@Pura |
Mm9::chr1:59820262..59820306,+ | p@chr1:59820262..59820306 + |
Mm9::chr3:7503423..7503503,+ | p1@Fam164a |
Mm9::chr5:67009875..67009950,- | p1@Apbb2 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0003690 | double-stranded DNA binding | 0.0134550899062544 |
GO:0048522 | positive regulation of cellular process | 0.0163456878692465 |
GO:0048518 | positive regulation of biological process | 0.0163456878692465 |
GO:0043566 | structure-specific DNA binding | 0.0163456878692465 |
GO:0030198 | extracellular matrix organization and biogenesis | 0.0163456878692465 |
GO:0046929 | negative regulation of neurotransmitter secretion | 0.0163456878692465 |
GO:0021897 | forebrain astrocyte development | 0.0163456878692465 |
GO:0021896 | forebrain astrocyte differentiation | 0.0163456878692465 |
GO:0043062 | extracellular structure organization and biogenesis | 0.0163456878692465 |
GO:0022011 | myelination in the peripheral nervous system | 0.0163456878692465 |
GO:0048712 | negative regulation of astrocyte differentiation | 0.0163456878692465 |
GO:0032292 | ensheathment of axons in the peripheral nervous system | 0.0163456878692465 |
GO:0046907 | intracellular transport | 0.0163456878692465 |
GO:0006915 | apoptosis | 0.0163456878692465 |
GO:0014065 | phosphoinositide 3-kinase cascade | 0.0163456878692465 |
GO:0046580 | negative regulation of Ras protein signal transduction | 0.0163456878692465 |
GO:0001937 | negative regulation of endothelial cell proliferation | 0.0163456878692465 |
GO:0048715 | negative regulation of oligodendrocyte differentiation | 0.0163456878692465 |
GO:0035021 | negative regulation of Rac protein signal transduction | 0.0163456878692465 |
GO:0048485 | sympathetic nervous system development | 0.0163456878692465 |
GO:0001953 | negative regulation of cell-matrix adhesion | 0.0163456878692465 |
GO:0014002 | astrocyte development | 0.0163456878692465 |
GO:0035035 | histone acetyltransferase binding | 0.0163456878692465 |
GO:0014044 | Schwann cell development | 0.0163456878692465 |
GO:0048853 | forebrain morphogenesis | 0.0163456878692465 |
GO:0045749 | negative regulation of S phase of mitotic cell cycle | 0.0163456878692465 |
GO:0032320 | positive regulation of Ras GTPase activity | 0.0163456878692465 |
GO:0012501 | programmed cell death | 0.0163456878692465 |
GO:0007399 | nervous system development | 0.0163456878692465 |
GO:0008219 | cell death | 0.0163456878692465 |
GO:0016265 | death | 0.0163456878692465 |
GO:0043525 | positive regulation of neuron apoptosis | 0.0163456878692465 |
GO:0048710 | regulation of astrocyte differentiation | 0.0163456878692465 |
GO:0001938 | positive regulation of endothelial cell proliferation | 0.0163456878692465 |
GO:0051224 | negative regulation of protein transport | 0.0163456878692465 |
GO:0048713 | regulation of oligodendrocyte differentiation | 0.0163456878692465 |
GO:0046823 | negative regulation of nucleocytoplasmic transport | 0.0163456878692465 |
GO:0048854 | brain morphogenesis | 0.0163456878692465 |
GO:0042308 | negative regulation of protein import into nucleus | 0.0163456878692465 |
GO:0042992 | negative regulation of transcription factor import into nucleus | 0.0163456878692465 |
GO:0051932 | synaptic transmission, GABAergic | 0.0163456878692465 |
GO:0032228 | regulation of synaptic transmission, GABAergic | 0.0163456878692465 |
GO:0048745 | smooth muscle development | 0.0163456878692465 |
GO:0022408 | negative regulation of cell-cell adhesion | 0.0163456878692465 |
GO:0043065 | positive regulation of apoptosis | 0.0163456878692465 |
GO:0043068 | positive regulation of programmed cell death | 0.0163456878692465 |
GO:0030029 | actin filament-based process | 0.0163456878692465 |
GO:0048731 | system development | 0.0163456878692465 |
GO:0051649 | establishment of cellular localization | 0.0163456878692465 |
GO:0008284 | positive regulation of cell proliferation | 0.0163456878692465 |
GO:0051641 | cellular localization | 0.0163456878692465 |
GO:0048844 | artery morphogenesis | 0.0163456878692465 |
GO:0031575 | G1/S transition checkpoint | 0.0163456878692465 |
GO:0033261 | regulation of progression through S phase | 0.0163456878692465 |
GO:0045930 | negative regulation of progression through mitotic cell cycle | 0.0163456878692465 |
GO:0030132 | clathrin coat of coated pit | 0.0163456878692465 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 0.0163456878692465 |
GO:0043409 | negative regulation of MAPKKK cascade | 0.0163456878692465 |
GO:0005662 | DNA replication factor A complex | 0.0163456878692465 |
GO:0000074 | regulation of progression through cell cycle | 0.0163456878692465 |
GO:0048646 | anatomical structure formation | 0.01699335735862 |
GO:0008134 | transcription factor binding | 0.01699335735862 |
GO:0014014 | negative regulation of gliogenesis | 0.01699335735862 |
GO:0045686 | negative regulation of glial cell differentiation | 0.01699335735862 |
GO:0001936 | regulation of endothelial cell proliferation | 0.01699335735862 |
GO:0007406 | negative regulation of neuroblast proliferation | 0.01699335735862 |
GO:0035020 | regulation of Rac protein signal transduction | 0.01699335735862 |
GO:0045124 | regulation of bone resorption | 0.01699335735862 |
GO:0051058 | negative regulation of small GTPase mediated signal transduction | 0.01699335735862 |
GO:0048708 | astrocyte differentiation | 0.0175351338662379 |
GO:0051320 | S phase | 0.0175351338662379 |
GO:0001540 | beta-amyloid binding | 0.0175351338662379 |
GO:0046332 | SMAD binding | 0.0175351338662379 |
GO:0000084 | S phase of mitotic cell cycle | 0.0175351338662379 |
GO:0030130 | clathrin coat of trans-Golgi network vesicle | 0.0175351338662379 |
GO:0048483 | autonomic nervous system development | 0.0175351338662379 |
GO:0001952 | regulation of cell-matrix adhesion | 0.0175351338662379 |
GO:0014037 | Schwann cell differentiation | 0.0175351338662379 |
GO:0048523 | negative regulation of cellular process | 0.0175794545976659 |
GO:0000278 | mitotic cell cycle | 0.0175794545976659 |
GO:0012510 | trans-Golgi network transport vesicle membrane | 0.0175794545976659 |
GO:0021987 | cerebral cortex development | 0.0175794545976659 |
GO:0042990 | regulation of transcription factor import into nucleus | 0.0175794545976659 |
GO:0045671 | negative regulation of osteoclast differentiation | 0.0175794545976659 |
GO:0042991 | transcription factor import into nucleus | 0.0175794545976659 |
GO:0050821 | protein stabilization | 0.0175794545976659 |
GO:0001935 | endothelial cell proliferation | 0.0175794545976659 |
GO:0048856 | anatomical structure development | 0.0175794545976659 |
GO:0048519 | negative regulation of biological process | 0.0175794545976659 |
GO:0042306 | regulation of protein import into nucleus | 0.0175794545976659 |
GO:0043601 | nuclear replisome | 0.0175794545976659 |
GO:0045685 | regulation of glial cell differentiation | 0.0175794545976659 |
GO:0031647 | regulation of protein stability | 0.0175794545976659 |
GO:0002762 | negative regulation of myeloid leukocyte differentiation | 0.0175794545976659 |
GO:0014013 | regulation of gliogenesis | 0.0175794545976659 |
GO:0022407 | regulation of cell-cell adhesion | 0.0175794545976659 |
GO:0030894 | replisome | 0.0175794545976659 |
GO:0033157 | regulation of intracellular protein transport | 0.0175794545976659 |
GO:0030325 | adrenal gland development | 0.0175794545976659 |
GO:0032386 | regulation of intracellular transport | 0.0175794545976659 |
GO:0043596 | nuclear replication fork | 0.0189606964011911 |
GO:0021782 | glial cell development | 0.0189606964011911 |
GO:0048709 | oligodendrocyte differentiation | 0.0189606964011911 |
GO:0051223 | regulation of protein transport | 0.0197054482809939 |
GO:0004675 | transmembrane receptor protein serine/threonine kinase activity | 0.0197054482809939 |
GO:0048169 | regulation of long-term neuronal synaptic plasticity | 0.0197054482809939 |
GO:0030660 | Golgi-associated vesicle membrane | 0.0197054482809939 |
GO:0005024 | transforming growth factor beta receptor activity | 0.0197054482809939 |
GO:0030658 | transport vesicle membrane | 0.0197054482809939 |
GO:0022403 | cell cycle phase | 0.0202095827569335 |
GO:0016477 | cell migration | 0.0204644015387217 |
GO:0046822 | regulation of nucleocytoplasmic transport | 0.0204644015387217 |
GO:0051048 | negative regulation of secretion | 0.0204644015387217 |
GO:0030140 | trans-Golgi network transport vesicle | 0.0204644015387217 |
GO:0009888 | tissue development | 0.0204644015387217 |
GO:0007275 | multicellular organismal development | 0.0204644015387217 |
GO:0030125 | clathrin vesicle coat | 0.0204644015387217 |
GO:0007093 | mitotic cell cycle checkpoint | 0.0204644015387217 |
GO:0051349 | positive regulation of lyase activity | 0.0204644015387217 |
GO:0030308 | negative regulation of cell growth | 0.0204644015387217 |
GO:0045762 | positive regulation of adenylate cyclase activity | 0.0204644015387217 |
GO:0007162 | negative regulation of cell adhesion | 0.0204644015387217 |
GO:0031281 | positive regulation of cyclase activity | 0.0204644015387217 |
GO:0021510 | spinal cord development | 0.0204644015387217 |
GO:0021543 | pallium development | 0.0215144537072125 |
GO:0030336 | negative regulation of cell migration | 0.0215144537072125 |
GO:0048168 | regulation of neuronal synaptic plasticity | 0.0215144537072125 |
GO:0045453 | bone resorption | 0.0220076795855186 |
GO:0045670 | regulation of osteoclast differentiation | 0.0220076795855186 |
GO:0016601 | Rac protein signal transduction | 0.0220076795855186 |
GO:0030665 | clathrin coated vesicle membrane | 0.0220076795855186 |
GO:0030048 | actin filament-based movement | 0.0220076795855186 |
GO:0030199 | collagen fibril organization | 0.0220076795855186 |
GO:0048699 | generation of neurons | 0.0224068643188616 |
GO:0042127 | regulation of cell proliferation | 0.0225163873294182 |
GO:0016525 | negative regulation of angiogenesis | 0.0227857160623316 |
GO:0045761 | regulation of adenylate cyclase activity | 0.0227857160623316 |
GO:0006928 | cell motility | 0.0228170981353696 |
GO:0051674 | localization of cell | 0.0228170981353696 |
GO:0048468 | cell development | 0.023096674058741 |
GO:0043407 | negative regulation of MAP kinase activity | 0.023096674058741 |
GO:0009653 | anatomical structure morphogenesis | 0.023096674058741 |
GO:0022008 | neurogenesis | 0.023096674058741 |
GO:0030133 | transport vesicle | 0.023096674058741 |
GO:0031279 | regulation of cyclase activity | 0.023096674058741 |
GO:0048593 | camera-type eye morphogenesis | 0.023096674058741 |
GO:0051051 | negative regulation of transport | 0.023096674058741 |
GO:0043408 | regulation of MAPKKK cascade | 0.023096674058741 |
GO:0051339 | regulation of lyase activity | 0.023096674058741 |
GO:0051271 | negative regulation of cell motility | 0.023096674058741 |
GO:0002761 | regulation of myeloid leukocyte differentiation | 0.023096674058741 |
GO:0046928 | regulation of neurotransmitter secretion | 0.023096674058741 |
GO:0051726 | regulation of cell cycle | 0.0237507957228263 |
GO:0040013 | negative regulation of locomotion | 0.0237507957228263 |
GO:0045792 | negative regulation of cell size | 0.0237507957228263 |
GO:0045638 | negative regulation of myeloid cell differentiation | 0.0237507957228263 |
GO:0030316 | osteoclast differentiation | 0.0240709248791205 |
GO:0050768 | negative regulation of neurogenesis | 0.0240709248791205 |
GO:0050804 | regulation of synaptic transmission | 0.0240709248791205 |
GO:0051969 | regulation of transmission of nerve impulse | 0.0240709248791205 |
GO:0007346 | regulation of progression through mitotic cell cycle | 0.0240709248791205 |
GO:0003697 | single-stranded DNA binding | 0.0240709248791205 |
GO:0001666 | response to hypoxia | 0.0248108579845035 |
GO:0001889 | liver development | 0.0248108579845035 |
GO:0048167 | regulation of synaptic plasticity | 0.0248108579845035 |
GO:0042981 | regulation of apoptosis | 0.0251050011782061 |
GO:0043067 | regulation of programmed cell death | 0.0253729548010551 |
GO:0007632 | visual behavior | 0.0253729548010551 |
GO:0008542 | visual learning | 0.0253729548010551 |
GO:0006886 | intracellular protein transport | 0.0259086891893655 |
GO:0007422 | peripheral nervous system development | 0.0259086891893655 |
GO:0021537 | telencephalon development | 0.0259086891893655 |
GO:0050803 | regulation of synapse structure and activity | 0.0259086891893655 |
GO:0007270 | nerve-nerve synaptic transmission | 0.0265699613075102 |
GO:0005657 | replication fork | 0.0265699613075102 |
GO:0030120 | vesicle coat | 0.0265699613075102 |
GO:0001707 | mesoderm formation | 0.0272087109496776 |
GO:0001894 | tissue homeostasis | 0.0272087109496776 |
GO:0045926 | negative regulation of growth | 0.0272087109496776 |
GO:0048332 | mesoderm morphogenesis | 0.0273748186859302 |
GO:0030662 | coated vesicle membrane | 0.0273748186859302 |
GO:0007405 | neuroblast proliferation | 0.0273748186859302 |
GO:0031644 | regulation of neurological process | 0.0273748186859302 |
GO:0048871 | multicellular organismal homeostasis | 0.0273748186859302 |
GO:0000075 | cell cycle checkpoint | 0.0273748186859302 |
GO:0042552 | myelination | 0.0278214804145908 |
GO:0001649 | osteoblast differentiation | 0.0278214804145908 |
GO:0007088 | regulation of mitosis | 0.0278214804145908 |
GO:0001704 | formation of primary germ layer | 0.0278214804145908 |
GO:0005798 | Golgi-associated vesicle | 0.0286953384310088 |
GO:0007272 | ensheathment of neurons | 0.0292533937047309 |
GO:0046850 | regulation of bone remodeling | 0.0292533937047309 |
GO:0008366 | axon ensheathment | 0.0292533937047309 |
GO:0045765 | regulation of angiogenesis | 0.0301011951816067 |
GO:0009790 | embryonic development | 0.0301363014826384 |
GO:0007010 | cytoskeleton organization and biogenesis | 0.0301363014826384 |
GO:0005905 | coated pit | 0.03062586274139 |
GO:0008283 | cell proliferation | 0.0317820467544107 |
GO:0032318 | regulation of Ras GTPase activity | 0.0322634666508231 |
GO:0030118 | clathrin coat | 0.0329049836176353 |
GO:0043523 | regulation of neuron apoptosis | 0.0329049836176353 |
GO:0032502 | developmental process | 0.0332440968863381 |
GO:0045637 | regulation of myeloid cell differentiation | 0.0335335459870207 |
GO:0006469 | negative regulation of protein kinase activity | 0.034149533003231 |
GO:0033673 | negative regulation of kinase activity | 0.034149533003231 |
GO:0001508 | regulation of action potential | 0.034922014638442 |
GO:0051402 | neuron apoptosis | 0.0351769147734034 |
GO:0051348 | negative regulation of transferase activity | 0.0351769147734034 |
GO:0030659 | cytoplasmic vesicle membrane | 0.0351769147734034 |
GO:0010001 | glial cell differentiation | 0.0351769147734034 |
GO:0002573 | myeloid leukocyte differentiation | 0.0368407362901451 |
GO:0005515 | protein binding | 0.0370502388151655 |
GO:0042063 | gliogenesis | 0.0370531235352101 |
GO:0051325 | interphase | 0.0370531235352101 |
GO:0051329 | interphase of mitotic cell cycle | 0.0370531235352101 |
GO:0048592 | eye morphogenesis | 0.0386679777962139 |
GO:0007050 | cell cycle arrest | 0.0397176846146631 |
GO:0050767 | regulation of neurogenesis | 0.0397176846146631 |
GO:0030155 | regulation of cell adhesion | 0.0397176846146631 |
GO:0001656 | metanephros development | 0.0397176846146631 |
GO:0022402 | cell cycle process | 0.0399943934116325 |
GO:0008017 | microtubule binding | 0.0400475292700703 |
GO:0004702 | receptor signaling protein serine/threonine kinase activity | 0.0400475292700703 |
GO:0043086 | negative regulation of catalytic activity | 0.0407287675598444 |
GO:0035270 | endocrine system development | 0.0414036682275784 |
GO:0044433 | cytoplasmic vesicle part | 0.0417032600792224 |
GO:0007498 | mesoderm development | 0.0417032600792224 |
GO:0007612 | learning | 0.0417032600792224 |
GO:0007269 | neurotransmitter secretion | 0.0431004978089489 |
GO:0050794 | regulation of cellular process | 0.0431004978089489 |
GO:0030117 | membrane coat | 0.0431004978089489 |
GO:0048475 | coated membrane | 0.0431004978089489 |
GO:0030334 | regulation of cell migration | 0.0431004978089489 |
GO:0051046 | regulation of secretion | 0.0431004978089489 |
GO:0048869 | cellular developmental process | 0.0441314655668843 |
GO:0030154 | cell differentiation | 0.0441314655668843 |
GO:0015631 | tubulin binding | 0.0445029206157498 |
GO:0007188 | G-protein signaling, coupled to cAMP nucleotide second messenger | 0.0445029206157498 |
GO:0001764 | neuron migration | 0.0445029206157498 |
GO:0065008 | regulation of biological quality | 0.0445029206157498 |
GO:0012506 | vesicle membrane | 0.0446674617431578 |
GO:0006606 | protein import into nucleus | 0.0446674617431578 |
GO:0035023 | regulation of Rho protein signal transduction | 0.0446674617431578 |
GO:0051170 | nuclear import | 0.0452713279105757 |
GO:0015031 | protein transport | 0.0455026347024982 |
GO:0007187 | G-protein signaling, coupled to cyclic nucleotide second messenger | 0.045683542693465 |
GO:0051270 | regulation of cell motility | 0.0462754481709401 |
GO:0043405 | regulation of MAP kinase activity | 0.0466741229496561 |
GO:0019933 | cAMP-mediated signaling | 0.0466741229496561 |
GO:0007369 | gastrulation | 0.0480212347133907 |
GO:0019935 | cyclic-nucleotide-mediated signaling | 0.0482043106355067 |
GO:0007160 | cell-matrix adhesion | 0.0482043106355067 |
GO:0040012 | regulation of locomotion | 0.0482043106355067 |
GO:0045184 | establishment of protein localization | 0.0482043106355067 |
GO:0045055 | regulated secretory pathway | 0.0482043106355067 |
GO:0043087 | regulation of GTPase activity | 0.0482043106355067 |
GO:0017038 | protein import | 0.0482043106355067 |
GO:0021915 | neural tube development | 0.0487597388117101 |
GO:0044454 | nuclear chromosome part | 0.0498570487141844 |
GO:0031589 | cell-substrate adhesion | 0.0498570487141844 |
GO:0043170 | macromolecule metabolic process | 0.0498574753935555 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
ectoderm-derived structure | 5.56e-13 | 95 |
ectoderm | 5.56e-13 | 95 |
presumptive ectoderm | 5.56e-13 | 95 |
ecto-epithelium | 4.26e-12 | 73 |
multi-cellular organism | 4.78e-12 | 333 |
structure with developmental contribution from neural crest | 5.86e-12 | 92 |
anatomical conduit | 5.91e-12 | 122 |
regional part of nervous system | 1.43e-11 | 54 |
neurectoderm | 8.25e-11 | 64 |
neural plate | 8.25e-11 | 64 |
presumptive neural plate | 8.25e-11 | 64 |
central nervous system | 1.28e-10 | 73 |
neural tube | 1.42e-10 | 52 |
neural rod | 1.42e-10 | 52 |
future spinal cord | 1.42e-10 | 52 |
neural keel | 1.42e-10 | 52 |
tube | 1.80e-10 | 114 |
nervous system | 2.33e-10 | 75 |
gray matter | 5.58e-10 | 34 |
brain | 1.06e-08 | 47 |
future brain | 1.06e-08 | 47 |
embryo | 1.52e-08 | 320 |
regional part of brain | 2.97e-08 | 46 |
brain grey matter | 4.43e-08 | 29 |
regional part of telencephalon | 4.43e-08 | 29 |
telencephalon | 4.43e-08 | 29 |
occipital lobe | 4.62e-08 | 10 |
visual cortex | 4.62e-08 | 10 |
neocortex | 4.62e-08 | 10 |
pre-chordal neural plate | 1.21e-07 | 49 |
anterior neural tube | 1.55e-07 | 40 |
regional part of forebrain | 4.80e-07 | 39 |
forebrain | 4.80e-07 | 39 |
future forebrain | 4.80e-07 | 39 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 5.04139 |
MA0004.1 | 1.02263 |
MA0006.1 | 0.670874 |
MA0007.1 | 0.38073 |
MA0009.1 | 0.82278 |
MA0014.1 | 2.09919 |
MA0017.1 | 0.26239 |
MA0019.1 | 0.642876 |
MA0024.1 | 0.779446 |
MA0025.1 | 1.05446 |
MA0027.1 | 2.46647 |
MA0028.1 | 0.24786 |
MA0029.1 | 0.757957 |
MA0030.1 | 0.764448 |
MA0031.1 | 0.729293 |
MA0038.1 | 0.534262 |
MA0040.1 | 0.835181 |
MA0041.1 | 0.323687 |
MA0042.1 | 0.311486 |
MA0043.1 | 0.918718 |
MA0046.1 | 0.858391 |
MA0048.1 | 1.47862 |
MA0050.1 | 0.431976 |
MA0051.1 | 0.542972 |
MA0052.1 | 0.84317 |
MA0055.1 | 0.221677 |
MA0056.1 | 0 |
MA0057.1 | 1.93392 |
MA0058.1 | 0.305206 |
MA0059.1 | 0.316585 |
MA0060.1 | 0.9744 |
MA0061.1 | 0.56663 |
MA0063.1 | 0 |
MA0066.1 | 1.29967 |
MA0067.1 | 1.16502 |
MA0068.1 | 0.077274 |
MA0069.1 | 0.843506 |
MA0070.1 | 0.833895 |
MA0071.1 | 0.431174 |
MA0072.1 | 0.825495 |
MA0073.1 | 0.00108891 |
MA0074.1 | 0.488775 |
MA0076.1 | 0.765781 |
MA0077.1 | 0.804033 |
MA0078.1 | 0.575205 |
MA0081.1 | 0.338098 |
MA0083.1 | 0.917931 |
MA0084.1 | 1.49188 |
MA0087.1 | 0.87515 |
MA0088.1 | 0.18495 |
MA0089.1 | 0 |
MA0090.1 | 0.362551 |
MA0091.1 | 0.407455 |
MA0092.1 | 0.362847 |
MA0093.1 | 0.709711 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.477594 |
MA0101.1 | 0.324888 |
MA0103.1 | 0.272167 |
MA0105.1 | 0.720048 |
MA0106.1 | 0.582805 |
MA0107.1 | 0.266586 |
MA0108.2 | 0.665343 |
MA0109.1 | 0 |
MA0111.1 | 0.375908 |
MA0113.1 | 0.555251 |
MA0114.1 | 0.561811 |
MA0115.1 | 0.921497 |
MA0116.1 | 0.670446 |
MA0117.1 | 0.88947 |
MA0119.1 | 0.325434 |
MA0122.1 | 0.909168 |
MA0124.1 | 1.11203 |
MA0125.1 | 1.03833 |
MA0130.1 | 0 |
MA0131.1 | 0.638414 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 0.954884 |
MA0136.1 | 0.508047 |
MA0139.1 | 0.867077 |
MA0140.1 | 0.477483 |
MA0141.1 | 0.29014 |
MA0142.1 | 0.714976 |
MA0143.1 | 0.571221 |
MA0144.1 | 0.195095 |
MA0145.1 | 0.442138 |
MA0146.1 | 3.35461 |
MA0147.1 | 1.12076 |
MA0148.1 | 0.410398 |
MA0149.1 | 0.330018 |
MA0062.2 | 0.738221 |
MA0035.2 | 0.482026 |
MA0039.2 | 1.36306 |
MA0138.2 | 0.630612 |
MA0002.2 | 0.145685 |
MA0137.2 | 0.287486 |
MA0104.2 | 0.926067 |
MA0047.2 | 0.533516 |
MA0112.2 | 0.442124 |
MA0065.2 | 0.44341 |
MA0150.1 | 0.380623 |
MA0151.1 | 0 |
MA0152.1 | 0.53362 |
MA0153.1 | 0.971406 |
MA0154.1 | 0.581988 |
MA0155.1 | 0.490492 |
MA0156.1 | 0.278949 |
MA0157.1 | 0.683365 |
MA0158.1 | 0 |
MA0159.1 | 0.214506 |
MA0160.1 | 0.413266 |
MA0161.1 | 0 |
MA0162.1 | 3.06145 |
MA0163.1 | 1.53225 |
MA0164.1 | 0.508398 |
MA0080.2 | 0.267388 |
MA0018.2 | 1.28741 |
MA0099.2 | 0.624421 |
MA0079.2 | 5.6867 |
MA0102.2 | 1.5442 |
MA0258.1 | 0.180934 |
MA0259.1 | 1.70624 |
MA0442.1 | 0 |